Investor appetite for commercial properties remains solid so far, despite recent geopolitical instability. In March, the commercial property marketplace experienced the strongest annual gain in prices ...

MDD: Emerge topline data readout on track for late 2Q 2026; Ascend sites activated with first patient dosing anticipated in 2Q 2026 GAD: Voyage enrollment complete with 214 patients with topline data ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Migraines are very overwhelming, particularly when seeking the appropriate treatment. All these drugs can be confusing, and it is hard to know which ones are effective, how medications are different, ...

Ubrelvy (ubrogepant) and Nurtec ODT (rimegepant) are prescription drugs used to treat migraine episodes. Ubrelvy comes as a tablet that you swallow. Nurtec ODT comes as a tablet that dissolves on or ...

Nurtec ODT (rimegepant) may not be safe to take while pregnant or breastfeeding. Certain factors may determine whether you should take the drug during this time. If you may be or can become pregnant, ...

With JetBrains making its Rider and WebStorm IDEs freely available for non-commercial use, Visual Studio 2022 Community Edition has a new competitor, not to mention Visual Studio Code. So what's a ...

Its not known whether Nurtec ODT (rimegepant) is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine ...

Pfizer has agreed to pay $59.75 million to settle claims that Biohaven Pharmaceutical Holding Co., which it acquired in 2022, defrauded Medicare and other healthcare programs by paying kickbacks to ...

World-recognized brand Pfizer has agreed to a nearly $60 million financial agreement to settle claims that a wholly-owned subsidiary, Biohaven Pharmaceutical Holding Company Ltd. (Biohaven), breached ...

Pfizer, on behalf of its subsidiary Biohaven Pharmaceutical Holding Company, agreed to pay $59,746,277 to resolve allegations that prior to Pfizer’s acquisition, Biohaven paid kickbacks to physicians ...